Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma (Q74336550)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

M Chokri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M C Jacob

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P Drillat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

F Garban

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

H Egelhofer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J P Molens

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J J Sotto

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J C Bensa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Plumas

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

1667-1677

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10995015%20AND%20SRC:MED&resulttype=core&format=json

Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Immune therapy with macrophages: present status and critical requirements for implementation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Phase I/II trial of autologous activated macrophages in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Adoptive immunotherapy with bispecific antibodies: targeting through macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Monocyte-derived dendritic cells: development of a cellular processor for clinical applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Generation of phagocytic MAK and MAC-DC for therapeutic use

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Phagocytosis of antigens by Langerhans cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Immune interferon: a pleiotropic lymphokine with multiple effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021

Cellular requirements for the monoclonal antibody-mediated eradication of an established solid tumor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401888

7 January 2021